DB16401InvestigationalVaccines
Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
- Code names
- BNT-162C2
Resolves to
Compound
What you can answer from here — as of February 21, 2021
Which companies are running trials of Pidacmeran, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account